Form 4 for WGS GeneDx Holdings Corp.
Accepted 2021-07-26 00:00:00 ET · period of report 2021-07-22 · accession 0001209191-21-048227 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-26 | 2021-07-22 | WGS | Leproust Emily M. | Dir | C - Cnv Deriv | $0.00 | +25.0K | 25.0K | New | $0 |
| D | 2021-07-26 | 2021-07-22 | WGS | Leproust Emily M. | Dir | C - Cnv Deriv | — | -25.0K | 0 | -100% | — |
| D | 2021-07-26 | 2021-07-22 | WGS | Leproust Emily M. | Dir | A - Grant | $11.50 | +166.7K | 166.7K | New | +$1.92M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-22 | C | A | 25,000 | $0.00 | 25,000 | D | — | — | |
| 2 | Derivative | Class B Common Stock | 2021-07-22 | C | D | 25,000 | — | 0 | D | — · — to — | 25,000 Class A Common Stock | (F1) In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as CM Life Sciences, Inc. or "CMLS") and Mount Sinai Genomics, Inc. d/b/a Sema4 ("Sema4"), among other things, each share of CMLS's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis. |
| 3 | Derivative | Private Placement Warrants | 2021-07-22 | A | A | 166,666 | $11.50 | 166,666 | D | $11.50 · — to — | 166,666 Class A Common Stock | (F2) In connection with the consummation of the Business Combination, all of the private placement warrants of CMLS held by the Reporting Person, which previously entitled the Reporting Person to purchase one share of CMLS's Class A Common Stock at a price of $11.50 per whole share at any time commencing on the later of 12 months from the closing of CMLS's initial public offering or 30 days after the completion of an initial business combination of CMLS, were converted into private placement warrants of Issuer (each a "New Private Placement Warrant") simultaneously with the closing of the Business Combination, with each whole New Private Placement Warrant entitling the holder thereof to the right to purchase one share of Issuer's Class A Common Stock. |